Acorda Therapeutics to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming 13th Annual BIO CEO & Investor Conference on Monday, February 14, 2011 at 10:00 a.m. Eastern Time at the Waldorf=Astoria in New York, NY.

MORE ON THIS TOPIC